Journal article
The effect of dose on the antimalarial efficacy of artemether-lumefantrine: A systematic review and pooled analysis of individual patient data
NM Anstey, RN Price, TME Davis, HA Karunajeewa, I Mueller, U D'Alessandro, A Massougbodji, F Nikiema, JB Ouédraogo, H Tinto, I Zongo, A Same-Ekobo, M Koné, H Menan, W Yavo, AO Touré, PE Kofoed, BH Alemayehu, D Jima, E Baudin Show all
Lancet Infectious Diseases | Published : 2015
Abstract
Background: Artemether-lumefantrine is the most widely used artemisinin-based combination therapy for malaria, although treatment failures occur in some regions. We investigated the effect of dosing strategy on efficacy in a pooled analysis from trials done in a wide range of malaria-endemic settings. Methods: We searched PubMed for clinical trials that enrolled and treated patients with artemether-lumefantrine and were published from 1960 to December, 2012. We merged individual patient data from these trials by use of standardised methods. The primary endpoint was the PCR-adjusted risk of Plasmodium falciparum recrudescence by day 28. Secondary endpoints consisted of the PCR-adjusted risk o..
View full abstractGrants
Awarded by Novartis
Funding Acknowledgements
Bill & Melinda Gates Foundation.